2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
7
Colorectal Neoplasms
6
Biliary Tract Neoplasms
5
Sarcoma
3
Rectal Neoplasms
3
Colonic Neoplasms
3
Advanced or Metastatic Solid Tumors
3
Uterine Cervical Neoplasms
2
Solid Tumors
2
Nasopharyngeal Carcinoma
2
Gastrointestinal Stromal Tumors
2
Carcinoma, Ovarian Epithelial
2
Carcinoma, Hepatocellular
2
Thymoma
1
Stomach Neoplasms
1
Squamous Non-small Cell Lung Cancer
1
Solid Tumor
1
Small Cell Lung Carcinoma
1
Rare Tumour
1
Prostatic Neoplasms
1
Piebaldism
1
Pancreatic Neoplasms
1
Osteosarcoma
1
Neoplasms, Multiple Primary
1
Neoplasm Metastasis
1
NSCLC
1
Meningeal Carcinomatosis
1
Lung Neoplasms
1
Locally Advanced Rectal Carcinoma
1
Histiocytoma, Malignant Fibrous
1
Interventions
envafolimab
1
Radiotherapy
1
Chemoradiotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasms, Multiple Primary
×
envafolimab
×
Clear all
NCT04182789
2019-12-02
CPOG035-01
RenJi Hospital
Phase 2
Unknown
20 enrolled